
Vivos Therapeutics Inc
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Vivos Therapeutics' stock with a target price of $6.20, indicating good growth potential.
Financial Health
Vivos Therapeutics is generating moderate revenue and cash flow, with a reasonable profit margin.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring VVOS
Immersive Rehab & VR Therapy
Virtual and augmented reality are transforming healthcare with innovative digital treatments for physical and psychological healing. These carefully selected companies are at the forefront of creating immersive technologies that offer effective alternatives to traditional therapies, poised to benefit from growing clinical acceptance.
Published: June 17, 2025
Explore BasketRest & Recharge
Tap into the booming wellness economy with companies revolutionizing how we sleep and relax. These carefully selected stocks represent innovative leaders in sleep technology, relaxation services, and wellness solutions that are responding to our growing desire for better rest and recovery.
Published: June 17, 2025
Explore BasketRest & Recovery
This carefully curated collection features companies at the forefront of sleep science and recovery technology. These stocks represent a growing market where innovation meets wellness, selected by professional analysts tracking the expanding health optimization trend.
Published: June 17, 2025
Explore BasketWhy Youβll Want to Watch This Stock
Sleep therapy growth
Rising awareness of sleep apnoea and interest in nonβCPAP options could create market opportunity, though clinical adoption and reimbursement will determine impact.
Smallβcap volatility
With a market cap around $20M, shares can be illiquid and volatile; this profile suits investors ready to accept higher risk and potential price swings.
Regulation and adoption
Regulatory approvals, clinical evidence and provider uptake are key growth leversβoutcomes here can materially influence future performance.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.